Drug & intervention
Combivir
RxCUI 192254
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Combivir
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
5 shownA Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™NCT01597648 · 2011-11-01
COMPLETEDSwitch From Combivir or Trizivir to Truvada - Mitochondrial EffectsNCT00960622 · 2006-08-01
COMPLETEDGW873140 In Combination With Combivir In HIV Infected SubjectsNCT00104429 · 2005-01-01
TERMINATEDA Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIVNCT00082394 · 2004-04-26
COMPLETEDStudy to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIRNCT00043888 · 2002-01-01
COMPLETEDConditions being studied
Research locations
PhiladelphiaPennsylvania, United States3Washington D.C.District of Columbia, United States3AtlantaGeorgia, United States2BakersfieldCalifornia, United States2ChicagoIllinois, United States2DallasTexas, United States2DenverColorado, United States2Fort LauderdaleFlorida, United States2GreenvilleNorth Carolina, United States2LondonUnited Kingdom2Los AngelesCalifornia, United States2LyonFrance2
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.